vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and BlackSky Technology Inc. (BKSY). Click either name above to swap in a different company.
BlackSky Technology Inc. is the larger business by last-quarter revenue ($35.2M vs $21.2M, roughly 1.7× Autolus Therapeutics plc). BlackSky Technology Inc. runs the higher net margin — -2.5% vs -373.3%, a 370.8% gap on every dollar of revenue.
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
BlackSky Technology Inc. is a leading geospatial intelligence provider operating a constellation of high-revisit small Earth observation satellites. It delivers real-time satellite imagery, advanced data analytics, and dynamic monitoring solutions to government, defense, critical infrastructure, and commercial clients globally to support data-driven operational decision-making.
AUTL vs BKSY — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $35.2M |
| Net Profit | $-79.1M | $-868.0K |
| Gross Margin | — | — |
| Operating Margin | -337.9% | -11.8% |
| Net Margin | -373.3% | -2.5% |
| Revenue YoY | — | 15.9% |
| Net Profit YoY | 3.6% | 95.5% |
| EPS (diluted) | $-0.30 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $35.2M | ||
| Q3 25 | $21.2M | $19.6M | ||
| Q2 25 | $20.9M | $22.2M | ||
| Q1 25 | $9.0M | $29.5M | ||
| Q4 24 | — | $30.4M | ||
| Q3 24 | $0 | $22.5M | ||
| Q2 24 | $0 | $24.9M | ||
| Q1 24 | $10.1M | $24.2M |
| Q4 25 | — | $-868.0K | ||
| Q3 25 | $-79.1M | $-15.3M | ||
| Q2 25 | $-47.9M | $-41.2M | ||
| Q1 25 | $-70.2M | $-12.8M | ||
| Q4 24 | — | $-19.4M | ||
| Q3 24 | $-82.1M | $-12.6M | ||
| Q2 24 | $-58.3M | $-9.4M | ||
| Q1 24 | $-52.7M | $-15.8M |
| Q4 25 | — | -11.8% | ||
| Q3 25 | -337.9% | -85.8% | ||
| Q2 25 | -292.6% | -62.8% | ||
| Q1 25 | -726.3% | -40.5% | ||
| Q4 24 | — | -20.0% | ||
| Q3 24 | — | -58.7% | ||
| Q2 24 | — | -47.0% | ||
| Q1 24 | -384.1% | -54.7% |
| Q4 25 | — | -2.5% | ||
| Q3 25 | -373.3% | -78.2% | ||
| Q2 25 | -229.0% | -185.8% | ||
| Q1 25 | -781.1% | -43.4% | ||
| Q4 24 | — | -63.9% | ||
| Q3 24 | — | -55.8% | ||
| Q2 24 | — | -37.7% | ||
| Q1 24 | -522.1% | -65.2% |
| Q4 25 | — | $0.04 | ||
| Q3 25 | $-0.30 | $-0.44 | ||
| Q2 25 | $-0.18 | $-1.27 | ||
| Q1 25 | $-0.26 | $-0.42 | ||
| Q4 24 | — | $-0.61 | ||
| Q3 24 | $-0.31 | $-0.66 | ||
| Q2 24 | $-0.22 | $-0.52 | ||
| Q1 24 | $-0.24 | $-0.88 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $124.5M |
| Total DebtLower is stronger | — | $201.1M |
| Stockholders' EquityBook value | $265.5M | $94.9M |
| Total Assets | $661.9M | $386.2M |
| Debt / EquityLower = less leverage | — | 2.12× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $124.5M | ||
| Q3 25 | $86.1M | $146.5M | ||
| Q2 25 | $123.8M | $93.8M | ||
| Q1 25 | $95.8M | $75.8M | ||
| Q4 24 | — | $52.5M | ||
| Q3 24 | $657.1M | $63.2M | ||
| Q2 24 | $705.9M | $41.2M | ||
| Q1 24 | $758.5M | $35.4M |
| Q4 25 | — | $201.1M | ||
| Q3 25 | — | $195.1M | ||
| Q2 25 | — | $122.5M | ||
| Q1 25 | — | $115.3M | ||
| Q4 24 | — | $107.7M | ||
| Q3 24 | — | $98.8M | ||
| Q2 24 | — | $108.6M | ||
| Q1 24 | — | $85.0M |
| Q4 25 | — | $94.9M | ||
| Q3 25 | $265.5M | $91.1M | ||
| Q2 25 | $346.5M | $86.6M | ||
| Q1 25 | $371.1M | $88.8M | ||
| Q4 24 | — | $94.0M | ||
| Q3 24 | $477.0M | $110.3M | ||
| Q2 24 | $527.8M | $76.5M | ||
| Q1 24 | $582.0M | $81.7M |
| Q4 25 | — | $386.2M | ||
| Q3 25 | $661.9M | $380.9M | ||
| Q2 25 | $721.0M | $310.8M | ||
| Q1 25 | $746.3M | $284.9M | ||
| Q4 24 | — | $254.1M | ||
| Q3 24 | $827.5M | $245.5M | ||
| Q2 24 | $853.6M | $224.3M | ||
| Q1 24 | $901.4M | $210.1M |
| Q4 25 | — | 2.12× | ||
| Q3 25 | — | 2.14× | ||
| Q2 25 | — | 1.41× | ||
| Q1 25 | — | 1.30× | ||
| Q4 24 | — | 1.15× | ||
| Q3 24 | — | 0.90× | ||
| Q2 24 | — | 1.42× | ||
| Q1 24 | — | 1.04× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $-9.3M |
| Free Cash FlowOCF − Capex | $-72.3M | — |
| FCF MarginFCF / Revenue | -341.2% | — |
| Capex IntensityCapex / Revenue | 20.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-9.3M | ||
| Q3 25 | $-67.9M | $-39.0M | ||
| Q2 25 | $-72.8M | $-7.3M | ||
| Q1 25 | $-75.6M | $27.2M | ||
| Q4 24 | — | $-1.8M | ||
| Q3 24 | $-76.7M | $1.0M | ||
| Q2 24 | $-51.1M | $-1.8M | ||
| Q1 24 | $-40.5M | $-3.8M |
| Q4 25 | — | — | ||
| Q3 25 | $-72.3M | — | ||
| Q2 25 | $-80.1M | — | ||
| Q1 25 | $-83.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-86.3M | — | ||
| Q2 24 | $-51.9M | — | ||
| Q1 24 | $-41.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | -341.2% | — | ||
| Q2 25 | -382.6% | — | ||
| Q1 25 | -933.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -406.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 20.8% | — | ||
| Q2 25 | 34.8% | — | ||
| Q1 25 | 91.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.3% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
